1 | Representative(s) Sobel, Seiler, Gelber, Vana, and Cusack |
2 | offered the following: |
3 |
|
4 | Amendment to Senate Amendment (871600) (with directory and |
5 | title amendments) |
6 | On page 8, line(s) 23, through page 76, line 10, |
7 | remove: all of said lines |
8 |
|
9 | and insert: |
10 | Section 8. Paragraphs (a) and (b) of subsection (2) and |
11 | paragraph (b) of subsection (4) of section 409.911, Florida |
12 | Statutes, are amended to read: |
13 | 409.911 Disproportionate share program.--Subject to |
14 | specific allocations established within the General |
15 | Appropriations Act and any limitations established pursuant to |
16 | chapter 216, the agency shall distribute, pursuant to this |
17 | section, moneys to hospitals providing a disproportionate share |
18 | of Medicaid or charity care services by making quarterly |
19 | Medicaid payments as required. Notwithstanding the provisions of |
20 | s. 409.915, counties are exempt from contributing toward the |
21 | cost of this special reimbursement for hospitals serving a |
22 | disproportionate share of low-income patients. |
23 | (2) The Agency for Health Care Administration shall use |
24 | the following actual audited data to determine the Medicaid days |
25 | and charity care to be used in calculating the disproportionate |
26 | share payment: |
27 | (a) The average of the 1998, 1999, and 2000 audited |
28 | disproportionate share data to determine each hospital's |
29 | Medicaid days and charity care for the 2004-2005 state fiscal |
30 | year and the average of the 1999, 2000, and 2001 audited |
31 | disproportionate share data to determine the Medicaid days and |
32 | charity care for the 2005-2006 state fiscal year. |
33 | (b) If the Agency for Health Care Administration does not |
34 | have the prescribed 3 years of audited disproportionate share |
35 | data as noted in paragraph (a) for a hospital, the agency shall |
36 | use the average of the years of the audited disproportionate |
37 | share data as noted in paragraph (a) which is available. The |
38 | average of the audited disproportionate share data for the years |
39 | available if the Agency for Health Care Administration does not |
40 | have the prescribed 3 years of audited disproportionate share |
41 | data for a hospital. |
42 | (4) The following formulas shall be used to pay |
43 | disproportionate share dollars to public hospitals: |
44 | (b) For non-state government owned or operated hospitals |
45 | with 3,300 or more Medicaid days: |
46 | DSHP = [(.82 x HCCD/TCCD) + (.18 x HMD/TMD)] |
47 |
|
48 | x TAAPH |
49 | TAAPH = TAA - TAAMH |
50 | Where: |
51 | TAA = total available appropriation. |
52 | TAAPH = total amount available for public hospitals. |
53 | DSHP = disproportionate share hospital payments. |
54 | HMD = hospital Medicaid days. |
55 | TMD = total state Medicaid days for public hospitals. |
56 | HCCD = hospital charity care dollars. |
57 | TCCD = total state charity care dollars for public non- |
58 | state hospitals. |
59 | 1. For the 2005-2006 state fiscal year only, the DSHP for |
60 | the public nonstate hospitals shall be computed using a weighted |
61 | average of the disproportionate share payments for the 2004-2005 |
62 | state fiscal year which uses an average of the 1998, 1999, and |
63 | 2000 audited disproportionate share data and the |
64 | disproportionate share payments for the 2005-2006 state fiscal |
65 | year as computed using the formula above and using the average |
66 | of the 1999, 2000, and 2001 audited disproportionate share data. |
67 | The final DSHP for the public nonstate hospitals shall be |
68 | computed as an average using the calculated payments for the |
69 | 2005-2006 state fiscal year weighted at 65 percent and the |
70 | disproportionate share payments for the 2004-2005 state fiscal |
71 | year weighted at 35 percent. |
72 | 2. The TAAPH shall be reduced by $6,365,257 before |
73 | computing the DSHP for each public hospital. The $6,365,257 |
74 | shall be distributed equally between the public hospitals that |
75 | are also designated statutory teaching hospitals. |
76 | Section 9. Section 409.9112, Florida Statutes, is amended |
77 | to read: |
78 | 409.9112 Disproportionate share program for regional |
79 | perinatal intensive care centers.--In addition to the payments |
80 | made under s. 409.911, the Agency for Health Care Administration |
81 | shall design and implement a system of making disproportionate |
82 | share payments to those hospitals that participate in the |
83 | regional perinatal intensive care center program established |
84 | pursuant to chapter 383. This system of payments shall conform |
85 | with federal requirements and shall distribute funds in each |
86 | fiscal year for which an appropriation is made by making |
87 | quarterly Medicaid payments. Notwithstanding the provisions of |
88 | s. 409.915, counties are exempt from contributing toward the |
89 | cost of this special reimbursement for hospitals serving a |
90 | disproportionate share of low-income patients. For the state |
91 | fiscal year 2005-2006 2004-2005, the agency shall not distribute |
92 | moneys under the regional perinatal intensive care centers |
93 | disproportionate share program, except as noted in subsection |
94 | (2). In the event the Centers for Medicare and Medicaid Services |
95 | do not approve Florida's inpatient hospital state plan amendment |
96 | for the public disproportionate share program by January 1, |
97 | 2005, the agency may make payments to hospitals under the |
98 | regional perinatal intensive care centers disproportionate share |
99 | program. |
100 | (1) The following formula shall be used by the agency to |
101 | calculate the total amount earned for hospitals that participate |
102 | in the regional perinatal intensive care center program: |
103 | TAE = HDSP/THDSP |
104 | Where: |
105 | TAE = total amount earned by a regional perinatal intensive |
106 | care center. |
107 | HDSP = the prior state fiscal year regional perinatal |
108 | intensive care center disproportionate share payment to the |
109 | individual hospital. |
110 | THDSP = the prior state fiscal year total regional |
111 | perinatal intensive care center disproportionate share payments |
112 | to all hospitals. |
113 | (2) The total additional payment for hospitals that |
114 | participate in the regional perinatal intensive care center |
115 | program shall be calculated by the agency as follows: |
116 | TAP = TAE x TA |
117 | Where: |
118 | TAP = total additional payment for a regional perinatal |
119 | intensive care center. |
120 | TAE = total amount earned by a regional perinatal intensive |
121 | care center. |
122 | TA = total appropriation for the regional perinatal |
123 | intensive care center disproportionate share program. |
124 | (3) In order to receive payments under this section, a |
125 | hospital must be participating in the regional perinatal |
126 | intensive care center program pursuant to chapter 383 and must |
127 | meet the following additional requirements: |
128 | (a) Agree to conform to all departmental and agency |
129 | requirements to ensure high quality in the provision of |
130 | services, including criteria adopted by departmental and agency |
131 | rule concerning staffing ratios, medical records, standards of |
132 | care, equipment, space, and such other standards and criteria as |
133 | the department and agency deem appropriate as specified by rule. |
134 | (b) Agree to provide information to the department and |
135 | agency, in a form and manner to be prescribed by rule of the |
136 | department and agency, concerning the care provided to all |
137 | patients in neonatal intensive care centers and high-risk |
138 | maternity care. |
139 | (c) Agree to accept all patients for neonatal intensive |
140 | care and high-risk maternity care, regardless of ability to pay, |
141 | on a functional space-available basis. |
142 | (d) Agree to develop arrangements with other maternity and |
143 | neonatal care providers in the hospital's region for the |
144 | appropriate receipt and transfer of patients in need of |
145 | specialized maternity and neonatal intensive care services. |
146 | (e) Agree to establish and provide a developmental |
147 | evaluation and services program for certain high-risk neonates, |
148 | as prescribed and defined by rule of the department. |
149 | (f) Agree to sponsor a program of continuing education in |
150 | perinatal care for health care professionals within the region |
151 | of the hospital, as specified by rule. |
152 | (g) Agree to provide backup and referral services to the |
153 | department's county health departments and other low-income |
154 | perinatal providers within the hospital's region, including the |
155 | development of written agreements between these organizations |
156 | and the hospital. |
157 | (h) Agree to arrange for transportation for high-risk |
158 | obstetrical patients and neonates in need of transfer from the |
159 | community to the hospital or from the hospital to another more |
160 | appropriate facility. |
161 | (4) Hospitals which fail to comply with any of the |
162 | conditions in subsection (3) or the applicable rules of the |
163 | department and agency shall not receive any payments under this |
164 | section until full compliance is achieved. A hospital which is |
165 | not in compliance in two or more consecutive quarters shall not |
166 | receive its share of the funds. Any forfeited funds shall be |
167 | distributed by the remaining participating regional perinatal |
168 | intensive care center program hospitals. |
169 | Section 10. Section 409.9113, Florida Statutes, is amended |
170 | to read: |
171 | 409.9113 Disproportionate share program for teaching |
172 | hospitals.--In addition to the payments made under ss. 409.911 |
173 | and 409.9112, the Agency for Health Care Administration shall |
174 | make disproportionate share payments to statutorily defined |
175 | teaching hospitals for their increased costs associated with |
176 | medical education programs and for tertiary health care services |
177 | provided to the indigent. This system of payments shall conform |
178 | with federal requirements and shall distribute funds in each |
179 | fiscal year for which an appropriation is made by making |
180 | quarterly Medicaid payments. Notwithstanding s. 409.915, |
181 | counties are exempt from contributing toward the cost of this |
182 | special reimbursement for hospitals serving a disproportionate |
183 | share of low-income patients. For the state fiscal year 2005- |
184 | 2006 2004-2005, the agency shall not distribute moneys under the |
185 | teaching hospital disproportionate share program, except as |
186 | noted in subsection (2). In the event the Centers for Medicare |
187 | and Medicaid Services do not approve Florida's inpatient |
188 | hospital state plan amendment for the public disproportionate |
189 | share program by January 1, 2005, the agency may make payments |
190 | to hospitals under the teaching hospital disproportionate share |
191 | program. |
192 | (1) On or before September 15 of each year, the Agency for |
193 | Health Care Administration shall calculate an allocation |
194 | fraction to be used for distributing funds to state statutory |
195 | teaching hospitals. Subsequent to the end of each quarter of the |
196 | state fiscal year, the agency shall distribute to each statutory |
197 | teaching hospital, as defined in s. 408.07, an amount determined |
198 | by multiplying one-fourth of the funds appropriated for this |
199 | purpose by the Legislature times such hospital's allocation |
200 | fraction. The allocation fraction for each such hospital shall |
201 | be determined by the sum of three primary factors, divided by |
202 | three. The primary factors are: |
203 | (a) The number of nationally accredited graduate medical |
204 | education programs offered by the hospital, including programs |
205 | accredited by the Accreditation Council for Graduate Medical |
206 | Education and the combined Internal Medicine and Pediatrics |
207 | programs acceptable to both the American Board of Internal |
208 | Medicine and the American Board of Pediatrics at the beginning |
209 | of the state fiscal year preceding the date on which the |
210 | allocation fraction is calculated. The numerical value of this |
211 | factor is the fraction that the hospital represents of the total |
212 | number of programs, where the total is computed for all state |
213 | statutory teaching hospitals. |
214 | (b) The number of full-time equivalent trainees in the |
215 | hospital, which comprises two components: |
216 | 1. The number of trainees enrolled in nationally |
217 | accredited graduate medical education programs, as defined in |
218 | paragraph (a). Full-time equivalents are computed using the |
219 | fraction of the year during which each trainee is primarily |
220 | assigned to the given institution, over the state fiscal year |
221 | preceding the date on which the allocation fraction is |
222 | calculated. The numerical value of this factor is the fraction |
223 | that the hospital represents of the total number of full-time |
224 | equivalent trainees enrolled in accredited graduate programs, |
225 | where the total is computed for all state statutory teaching |
226 | hospitals. |
227 | 2. The number of medical students enrolled in accredited |
228 | colleges of medicine and engaged in clinical activities, |
229 | including required clinical clerkships and clinical electives. |
230 | Full-time equivalents are computed using the fraction of the |
231 | year during which each trainee is primarily assigned to the |
232 | given institution, over the course of the state fiscal year |
233 | preceding the date on which the allocation fraction is |
234 | calculated. The numerical value of this factor is the fraction |
235 | that the given hospital represents of the total number of full- |
236 | time equivalent students enrolled in accredited colleges of |
237 | medicine, where the total is computed for all state statutory |
238 | teaching hospitals. |
239 |
|
240 | The primary factor for full-time equivalent trainees is computed |
241 | as the sum of these two components, divided by two. |
242 | (c) A service index that comprises three components: |
243 | 1. The Agency for Health Care Administration Service |
244 | Index, computed by applying the standard Service Inventory |
245 | Scores established by the Agency for Health Care Administration |
246 | to services offered by the given hospital, as reported on |
247 | Worksheet A-2 for the last fiscal year reported to the agency |
248 | before the date on which the allocation fraction is calculated. |
249 | The numerical value of this factor is the fraction that the |
250 | given hospital represents of the total Agency for Health Care |
251 | Administration Service Index values, where the total is computed |
252 | for all state statutory teaching hospitals. |
253 | 2. A volume-weighted service index, computed by applying |
254 | the standard Service Inventory Scores established by the Agency |
255 | for Health Care Administration to the volume of each service, |
256 | expressed in terms of the standard units of measure reported on |
257 | Worksheet A-2 for the last fiscal year reported to the agency |
258 | before the date on which the allocation factor is calculated. |
259 | The numerical value of this factor is the fraction that the |
260 | given hospital represents of the total volume-weighted service |
261 | index values, where the total is computed for all state |
262 | statutory teaching hospitals. |
263 | 3. Total Medicaid payments to each hospital for direct |
264 | inpatient and outpatient services during the fiscal year |
265 | preceding the date on which the allocation factor is calculated. |
266 | This includes payments made to each hospital for such services |
267 | by Medicaid prepaid health plans, whether the plan was |
268 | administered by the hospital or not. The numerical value of |
269 | this factor is the fraction that each hospital represents of the |
270 | total of such Medicaid payments, where the total is computed for |
271 | all state statutory teaching hospitals. |
272 |
|
273 | The primary factor for the service index is computed as the sum |
274 | of these three components, divided by three. |
275 | (2) By October 1 of each year, the agency shall use the |
276 | following formula to calculate the maximum additional |
277 | disproportionate share payment for statutorily defined teaching |
278 | hospitals: |
279 | TAP = THAF x A |
280 | Where: |
281 | TAP = total additional payment. |
282 | THAF = teaching hospital allocation factor. |
283 | A = amount appropriated for a teaching hospital |
284 | disproportionate share program. |
285 | Section 11. Section 409.9117, Florida Statutes, is amended |
286 | to read: |
287 | 409.9117 Primary care disproportionate share program.--For |
288 | the state fiscal year 2005-2006 2004-2005, the agency shall not |
289 | distribute moneys under the primary care disproportionate share |
290 | program, except as noted in subsection (2). In the event the |
291 | Centers for Medicare and Medicaid Services do not approve |
292 | Florida's inpatient hospital state plan amendment for the public |
293 | disproportionate share program by January 1, 2005, the agency |
294 | may make payments to hospitals under the primary care |
295 | disproportionate share program. |
296 | (1) If federal funds are available for disproportionate |
297 | share programs in addition to those otherwise provided by law, |
298 | there shall be created a primary care disproportionate share |
299 | program. |
300 | (2) The following formula shall be used by the agency to |
301 | calculate the total amount earned for hospitals that participate |
302 | in the primary care disproportionate share program: |
303 | TAE = HDSP/THDSP |
304 | Where: |
305 | TAE = total amount earned by a hospital participating in |
306 | the primary care disproportionate share program. |
307 | HDSP = the prior state fiscal year primary care |
308 | disproportionate share payment to the individual hospital. |
309 | THDSP = the prior state fiscal year total primary care |
310 | disproportionate share payments to all hospitals. |
311 | (3) The total additional payment for hospitals that |
312 | participate in the primary care disproportionate share program |
313 | shall be calculated by the agency as follows: |
314 | TAP = TAE x TA |
315 | Where: |
316 | TAP = total additional payment for a primary care hospital. |
317 | TAE = total amount earned by a primary care hospital. |
318 | TA = total appropriation for the primary care |
319 | disproportionate share program. |
320 | (4) In the establishment and funding of this program, the |
321 | agency shall use the following criteria in addition to those |
322 | specified in s. 409.911, payments may not be made to a hospital |
323 | unless the hospital agrees to: |
324 | (a) Cooperate with a Medicaid prepaid health plan, if one |
325 | exists in the community. |
326 | (b) Ensure the availability of primary and specialty care |
327 | physicians to Medicaid recipients who are not enrolled in a |
328 | prepaid capitated arrangement and who are in need of access to |
329 | such physicians. |
330 | (c) Coordinate and provide primary care services free of |
331 | charge, except copayments, to all persons with incomes up to 100 |
332 | percent of the federal poverty level who are not otherwise |
333 | covered by Medicaid or another program administered by a |
334 | governmental entity, and to provide such services based on a |
335 | sliding fee scale to all persons with incomes up to 200 percent |
336 | of the federal poverty level who are not otherwise covered by |
337 | Medicaid or another program administered by a governmental |
338 | entity, except that eligibility may be limited to persons who |
339 | reside within a more limited area, as agreed to by the agency |
340 | and the hospital. |
341 | (d) Contract with any federally qualified health center, |
342 | if one exists within the agreed geopolitical boundaries, |
343 | concerning the provision of primary care services, in order to |
344 | guarantee delivery of services in a nonduplicative fashion, and |
345 | to provide for referral arrangements, privileges, and |
346 | admissions, as appropriate. The hospital shall agree to provide |
347 | at an onsite or offsite facility primary care services within 24 |
348 | hours to which all Medicaid recipients and persons eligible |
349 | under this paragraph who do not require emergency room services |
350 | are referred during normal daylight hours. |
351 | (e) Cooperate with the agency, the county, and other |
352 | entities to ensure the provision of certain public health |
353 | services, case management, referral and acceptance of patients, |
354 | and sharing of epidemiological data, as the agency and the |
355 | hospital find mutually necessary and desirable to promote and |
356 | protect the public health within the agreed geopolitical |
357 | boundaries. |
358 | (f) In cooperation with the county in which the hospital |
359 | resides, develop a low-cost, outpatient, prepaid health care |
360 | program to persons who are not eligible for the Medicaid |
361 | program, and who reside within the area. |
362 | (g) Provide inpatient services to residents within the |
363 | area who are not eligible for Medicaid or Medicare, and who do |
364 | not have private health insurance, regardless of ability to pay, |
365 | on the basis of available space, except that nothing shall |
366 | prevent the hospital from establishing bill collection programs |
367 | based on ability to pay. |
368 | (h) Work with the Florida Healthy Kids Corporation, the |
369 | Florida Health Care Purchasing Cooperative, and business health |
370 | coalitions, as appropriate, to develop a feasibility study and |
371 | plan to provide a low-cost comprehensive health insurance plan |
372 | to persons who reside within the area and who do not have access |
373 | to such a plan. |
374 | (i) Work with public health officials and other experts to |
375 | provide community health education and prevention activities |
376 | designed to promote healthy lifestyles and appropriate use of |
377 | health services. |
378 | (j) Work with the local health council to develop a plan |
379 | for promoting access to affordable health care services for all |
380 | persons who reside within the area, including, but not limited |
381 | to, public health services, primary care services, inpatient |
382 | services, and affordable health insurance generally. |
383 |
|
384 | Any hospital that fails to comply with any of the provisions of |
385 | this subsection, or any other contractual condition, may not |
386 | receive payments under this section until full compliance is |
387 | achieved. |
388 | Section 12. Section 409.91195, Florida Statutes, is |
389 | amended to read: |
390 | 409.91195 Medicaid Pharmaceutical and Therapeutics |
391 | Committee.--There is created a Medicaid Pharmaceutical and |
392 | Therapeutics Committee within the agency for Health Care |
393 | Administration for the purpose of developing a Medicaid |
394 | preferred drug list formulary pursuant to 42 U.S.C. s. 1396r-8. |
395 | (1) The Medicaid Pharmaceutical and Therapeutics committee |
396 | shall be composed comprised as specified in 42 U.S.C. s. 1396r-8 |
397 | and consist of 11 members appointed by the Governor. Four |
398 | members shall be physicians, licensed under chapter 458; one |
399 | member licensed under chapter 459; five members shall be |
400 | pharmacists licensed under chapter 465; and one member shall be |
401 | a consumer representative. The members shall be appointed to |
402 | serve for terms of 2 years from the date of their appointment. |
403 | Members may be appointed to more than one term. The agency for |
404 | Health Care Administration shall serve as staff for the |
405 | committee and assist them with all ministerial duties. The |
406 | Governor shall ensure that at least some of the members of the |
407 | Medicaid Pharmaceutical and Therapeutics committee represent |
408 | Medicaid participating physicians and pharmacies serving all |
409 | segments and diversity of the Medicaid population, and have |
410 | experience in either developing or practicing under a preferred |
411 | drug list formulary. At least one of the members shall represent |
412 | the interests of pharmaceutical manufacturers. |
413 | (2) Committee members shall select a chairperson and a |
414 | vice chairperson each year from the committee membership. |
415 | (3) The committee shall meet at least quarterly and may |
416 | meet at other times at the discretion of the chairperson and |
417 | members. The committee shall comply with rules adopted by the |
418 | agency, including notice of any meeting of the committee |
419 | pursuant to the requirements of the Administrative Procedure |
420 | Act. |
421 | (4) Upon recommendation of the Medicaid Pharmaceutical and |
422 | Therapeutics committee, the agency shall adopt a preferred drug |
423 | list as described in s. 409.912(39). To the extent feasible, the |
424 | committee shall review all drug classes included on in the |
425 | preferred drug list formulary at least every 12 months, and may |
426 | recommend additions to and deletions from the preferred drug |
427 | list formulary, such that the preferred drug list formulary |
428 | provides for medically appropriate drug therapies for Medicaid |
429 | patients which achieve cost savings contained in the General |
430 | Appropriations Act. |
431 | (5) Except for mental health-related drugs, antiretroviral |
432 | drugs, and drugs for nursing home residents and other |
433 | institutional residents, reimbursement of drugs not included on |
434 | the preferred drug list in the formulary is subject to prior |
435 | authorization. |
436 | (5)(6) The agency for Health Care Administration shall |
437 | publish and disseminate the preferred drug list formulary to all |
438 | Medicaid providers in the state by Internet posting on the |
439 | agency's website or in other media. |
440 | (6)(7) The committee shall ensure that interested parties, |
441 | including pharmaceutical manufacturers agreeing to provide a |
442 | supplemental rebate as outlined in this chapter, have an |
443 | opportunity to present public testimony to the committee with |
444 | information or evidence supporting inclusion of a product on the |
445 | preferred drug list. Such public testimony shall occur prior to |
446 | any recommendations made by the committee for inclusion or |
447 | exclusion from the preferred drug list. Upon timely notice, the |
448 | agency shall ensure that any drug that has been approved or had |
449 | any of its particular uses approved by the United States Food |
450 | and Drug Administration under a priority review classification |
451 | will be reviewed by the Medicaid Pharmaceutical and Therapeutics |
452 | committee at the next regularly scheduled meeting following 3 |
453 | months of distribution of the drug to the general public. To the |
454 | extent possible, upon notice by a manufacturer the agency shall |
455 | also schedule a product review for any new product at the next |
456 | regularly scheduled Medicaid Pharmaceutical and Therapeutics |
457 | Committee. |
458 | (8) Until the Medicaid Pharmaceutical and Therapeutics |
459 | Committee is appointed and a preferred drug list adopted by the |
460 | agency, the agency shall use the existing voluntary preferred |
461 | drug list adopted pursuant to s. 72, chapter 2000-367, Laws of |
462 | Florida. Drugs not listed on the voluntary preferred drug list |
463 | will require prior authorization by the agency or its |
464 | contractor. |
465 | (7)(9) The Medicaid Pharmaceutical and Therapeutics |
466 | committee shall develop its preferred drug list recommendations |
467 | by considering the clinical efficacy, safety, and cost- |
468 | effectiveness of a product. When the preferred drug formulary is |
469 | adopted by the agency, if a product on the formulary is one of |
470 | the first four brand-name drugs used by a recipient in a month |
471 | the drug shall not require prior authorization. |
472 | (8) Upon timely notice, the agency shall ensure that any |
473 | therapeutic class of drugs which includes a drug that has been |
474 | removed from distribution to the public by its manufacturer or |
475 | the United States Food and Drug Administration or has been |
476 | required to carry a black box warning label by the United States |
477 | Food and Drug Administration because of safety concerns is |
478 | reviewed by the committee at the next regularly scheduled |
479 | meeting. After such review, the committee must recommend whether |
480 | to retain the therapeutic class of drugs or subcategories of |
481 | drugs within a therapeutic class on the preferred drug list and |
482 | whether to institute prior authorization requirements necessary |
483 | to ensure patient safety. |
484 | (9)(10) The Medicaid Pharmaceutical and Therapeutics |
485 | Committee may also make recommendations to the agency regarding |
486 | the prior authorization of any prescribed drug covered by |
487 | Medicaid. |
488 | (10)(11) Medicaid recipients may appeal agency preferred |
489 | drug formulary decisions using the Medicaid fair hearing process |
490 | administered by the Department of Children and Family Services. |
491 | Section 13. Paragraph (b) of subsection (4), paragraphs |
492 | (e) and (f) of subsection (15), paragraph (a) of subsection |
493 | (39), and subsections (44) and (49) of section 409.912, Florida |
494 | Statutes, are amended, and subsection (50) is added to that |
495 | section, to read: |
496 | 409.912 Cost-effective purchasing of health care.--The |
497 | agency shall purchase goods and services for Medicaid recipients |
498 | in the most cost-effective manner consistent with the delivery |
499 | of quality medical care. To ensure that medical services are |
500 | effectively utilized, the agency may, in any case, require a |
501 | confirmation or second physician's opinion of the correct |
502 | diagnosis for purposes of authorizing future services under the |
503 | Medicaid program. This section does not restrict access to |
504 | emergency services or poststabilization care services as defined |
505 | in 42 C.F.R. part 438.114. Such confirmation or second opinion |
506 | shall be rendered in a manner approved by the agency. The agency |
507 | shall maximize the use of prepaid per capita and prepaid |
508 | aggregate fixed-sum basis services when appropriate and other |
509 | alternative service delivery and reimbursement methodologies, |
510 | including competitive bidding pursuant to s. 287.057, designed |
511 | to facilitate the cost-effective purchase of a case-managed |
512 | continuum of care. The agency shall also require providers to |
513 | minimize the exposure of recipients to the need for acute |
514 | inpatient, custodial, and other institutional care and the |
515 | inappropriate or unnecessary use of high-cost services. The |
516 | agency may mandate prior authorization, drug therapy management, |
517 | or disease management participation for certain populations of |
518 | Medicaid beneficiaries, certain drug classes, or particular |
519 | drugs to prevent fraud, abuse, overuse, and possible dangerous |
520 | drug interactions. The Pharmaceutical and Therapeutics Committee |
521 | shall make recommendations to the agency on drugs for which |
522 | prior authorization is required. The agency shall inform the |
523 | Pharmaceutical and Therapeutics Committee of its decisions |
524 | regarding drugs subject to prior authorization. The agency is |
525 | authorized to limit the entities it contracts with or enrolls as |
526 | Medicaid providers by developing a provider network through |
527 | provider credentialing. The agency may limit its network based |
528 | on the assessment of beneficiary access to care, provider |
529 | availability, provider quality standards, time and distance |
530 | standards for access to care, the cultural competence of the |
531 | provider network, demographic characteristics of Medicaid |
532 | beneficiaries, practice and provider-to-beneficiary standards, |
533 | appointment wait times, beneficiary use of services, provider |
534 | turnover, provider profiling, provider licensure history, |
535 | previous program integrity investigations and findings, peer |
536 | review, provider Medicaid policy and billing compliance records, |
537 | clinical and medical record audits, and other factors. Providers |
538 | shall not be entitled to enrollment in the Medicaid provider |
539 | network. The agency is authorized to seek federal waivers |
540 | necessary to implement this policy. |
541 | (4) The agency may contract with: |
542 | (b) An entity that is providing comprehensive behavioral |
543 | health care services to certain Medicaid recipients through a |
544 | capitated, prepaid arrangement pursuant to the federal waiver |
545 | provided for by s. 409.905(5). Such an entity must be licensed |
546 | under chapter 624, chapter 636, or chapter 641 and must possess |
547 | the clinical systems and operational competence to manage risk |
548 | and provide comprehensive behavioral health care to Medicaid |
549 | recipients. As used in this paragraph, the term "comprehensive |
550 | behavioral health care services" means covered mental health and |
551 | substance abuse treatment services that are available to |
552 | Medicaid recipients. The secretary of the Department of Children |
553 | and Family Services shall approve provisions of procurements |
554 | related to children in the department's care or custody prior to |
555 | enrolling such children in a prepaid behavioral health plan. Any |
556 | contract awarded under this paragraph must be competitively |
557 | procured. In developing the behavioral health care prepaid plan |
558 | procurement document, the agency shall ensure that the |
559 | procurement document requires the contractor to develop and |
560 | implement a plan to ensure compliance with s. 394.4574 related |
561 | to services provided to residents of licensed assisted living |
562 | facilities that hold a limited mental health license. Except as |
563 | provided in subparagraph 8., the agency shall seek federal |
564 | approval to contract with a single entity meeting these |
565 | requirements to provide comprehensive behavioral health care |
566 | services to all Medicaid recipients not enrolled in a managed |
567 | care plan in an AHCA area. Each entity must offer sufficient |
568 | choice of providers in its network to ensure recipient access to |
569 | care and the opportunity to select a provider with whom they are |
570 | satisfied. The network shall include all public mental health |
571 | hospitals. To ensure unimpaired access to behavioral health care |
572 | services by Medicaid recipients, all contracts issued pursuant |
573 | to this paragraph shall require 80 percent of the capitation |
574 | paid to the managed care plan, including health maintenance |
575 | organizations, to be expended for the provision of behavioral |
576 | health care services. In the event the managed care plan expends |
577 | less than 80 percent of the capitation paid pursuant to this |
578 | paragraph for the provision of behavioral health care services, |
579 | the difference shall be returned to the agency. The agency shall |
580 | provide the managed care plan with a certification letter |
581 | indicating the amount of capitation paid during each calendar |
582 | year for the provision of behavioral health care services |
583 | pursuant to this section. The agency may reimburse for substance |
584 | abuse treatment services on a fee-for-service basis until the |
585 | agency finds that adequate funds are available for capitated, |
586 | prepaid arrangements. |
587 | 1. By January 1, 2001, the agency shall modify the |
588 | contracts with the entities providing comprehensive inpatient |
589 | and outpatient mental health care services to Medicaid |
590 | recipients in Hillsborough, Highlands, Hardee, Manatee, and Polk |
591 | Counties, to include substance abuse treatment services. |
592 | 2. By July 1, 2003, the agency and the Department of |
593 | Children and Family Services shall execute a written agreement |
594 | that requires collaboration and joint development of all policy, |
595 | budgets, procurement documents, contracts, and monitoring plans |
596 | that have an impact on the state and Medicaid community mental |
597 | health and targeted case management programs. |
598 | 3. Except as provided in subparagraph 8., by July 1, 2006, |
599 | the agency and the Department of Children and Family Services |
600 | shall contract with managed care entities in each AHCA area |
601 | except area 6 or arrange to provide comprehensive inpatient and |
602 | outpatient mental health and substance abuse services through |
603 | capitated prepaid arrangements to all Medicaid recipients who |
604 | are eligible to participate in such plans under federal law and |
605 | regulation. In AHCA areas where eligible individuals number less |
606 | than 150,000, the agency shall contract with a single managed |
607 | care plan to provide comprehensive behavioral health services to |
608 | all recipients who are not enrolled in a Medicaid health |
609 | maintenance organization. The agency may contract with more than |
610 | one comprehensive behavioral health provider to provide care to |
611 | recipients who are not enrolled in a Medicaid health maintenance |
612 | organization in AHCA areas where the eligible population exceeds |
613 | 150,000. Contracts for comprehensive behavioral health providers |
614 | awarded pursuant to this section shall be competitively |
615 | procured. Both for-profit and not-for-profit corporations shall |
616 | be eligible to compete. Managed care plans contracting with the |
617 | agency under subsection (3) shall provide and receive payment |
618 | for the same comprehensive behavioral health benefits as |
619 | provided in AHCA rules, including handbooks incorporated by |
620 | reference. In AHCA Area 11, the agency shall contract with at |
621 | least two comprehensive behavioral health care providers to |
622 | provide behavioral health care to recipients in that area who |
623 | are enrolled in, or assigned to, the MediPass program. One of |
624 | the behavioral health care contracts shall be with the existing |
625 | provider service network pilot project, as described in |
626 | paragraph (d), for the purpose of demonstrating the cost- |
627 | effectiveness of the provision of quality mental health services |
628 | through a public hospital-operated managed care model. Payment |
629 | shall be at an agreed-upon capitated rate to ensure cost |
630 | savings. Of the recipients in Area 11 who are assigned to |
631 | MediPass under the provisions of s. 409.9122(2)(k), a minimum of |
632 | 50,000 of those MediPass-enrolled recipients shall be assigned |
633 | to the existing provider service network in Area 11 for their |
634 | behavioral care. |
635 | 4. By October 1, 2003, the agency and the department shall |
636 | submit a plan to the Governor, the President of the Senate, and |
637 | the Speaker of the House of Representatives which provides for |
638 | the full implementation of capitated prepaid behavioral health |
639 | care in all areas of the state. |
640 | a. Implementation shall begin in 2003 in those AHCA areas |
641 | of the state where the agency is able to establish sufficient |
642 | capitation rates. |
643 | b. If the agency determines that the proposed capitation |
644 | rate in any area is insufficient to provide appropriate |
645 | services, the agency may adjust the capitation rate to ensure |
646 | that care will be available. The agency and the department may |
647 | use existing general revenue to address any additional required |
648 | match but may not over-obligate existing funds on an annualized |
649 | basis. |
650 | c. Subject to any limitations provided for in the General |
651 | Appropriations Act, the agency, in compliance with appropriate |
652 | federal authorization, shall develop policies and procedures |
653 | that allow for certification of local and state funds. |
654 | 5. Children residing in a statewide inpatient psychiatric |
655 | program, or in a Department of Juvenile Justice or a Department |
656 | of Children and Family Services residential program approved as |
657 | a Medicaid behavioral health overlay services provider shall not |
658 | be included in a behavioral health care prepaid health plan or |
659 | any other Medicaid managed care plan pursuant to this paragraph. |
660 | 6. In converting to a prepaid system of delivery, the |
661 | agency shall in its procurement document require an entity |
662 | providing only comprehensive behavioral health care services to |
663 | prevent the displacement of indigent care patients by enrollees |
664 | in the Medicaid prepaid health plan providing behavioral health |
665 | care services from facilities receiving state funding to provide |
666 | indigent behavioral health care, to facilities licensed under |
667 | chapter 395 which do not receive state funding for indigent |
668 | behavioral health care, or reimburse the unsubsidized facility |
669 | for the cost of behavioral health care provided to the displaced |
670 | indigent care patient. |
671 | 7. Traditional community mental health providers under |
672 | contract with the Department of Children and Family Services |
673 | pursuant to part IV of chapter 394, child welfare providers |
674 | under contract with the Department of Children and Family |
675 | Services in areas 1 and 6, and inpatient mental health providers |
676 | licensed pursuant to chapter 395 must be offered an opportunity |
677 | to accept or decline a contract to participate in any provider |
678 | network for prepaid behavioral health services. |
679 | 8. For fiscal year 2004-2005, all Medicaid eligible |
680 | children, except children in areas 1 and 6, whose cases are open |
681 | for child welfare services in the HomeSafeNet system, shall be |
682 | enrolled in MediPass or in Medicaid fee-for-service and all |
683 | their behavioral health care services including inpatient, |
684 | outpatient psychiatric, community mental health, and case |
685 | management shall be reimbursed on a fee-for-service basis. |
686 | Beginning July 1, 2005, such children, who are open for child |
687 | welfare services in the HomeSafeNet system, shall receive their |
688 | behavioral health care services through a specialty prepaid plan |
689 | operated by community-based lead agencies either through a |
690 | single agency or formal agreements among several agencies. The |
691 | specialty prepaid plan must result in savings to the state |
692 | comparable to savings achieved in other Medicaid managed care |
693 | and prepaid programs. Such plan must provide mechanisms to |
694 | maximize state and local revenues. The specialty prepaid plan |
695 | shall be developed by the agency and the Department of Children |
696 | and Family Services. The agency is authorized to seek any |
697 | federal waivers to implement this initiative. |
698 | (15) |
699 | (e) By January 15 of each year, the agency shall submit a |
700 | report to the Legislature and the Office of Long-Term-Care |
701 | Policy describing the operations of the CARES program. The |
702 | report must describe: |
703 | 1. Rate of diversion to community alternative programs; |
704 | 2. CARES program staffing needs to achieve additional |
705 | diversions; |
706 | 3. Reasons the program is unable to place individuals in |
707 | less restrictive settings when such individuals desired such |
708 | services and could have been served in such settings; |
709 | 4. Barriers to appropriate placement, including barriers |
710 | due to policies or operations of other agencies or state-funded |
711 | programs; and |
712 | 5. Statutory changes necessary to ensure that individuals |
713 | in need of long-term care services receive care in the least |
714 | restrictive environment. |
715 | (f) The Department of Elderly Affairs shall track |
716 | individuals over time who are assessed under the CARES program |
717 | and who are diverted from nursing home placement. By January 15 |
718 | of each year, the department shall submit to the Legislature and |
719 | the Office of Long-Term-Care Policy a longitudinal study of the |
720 | individuals who are diverted from nursing home placement. The |
721 | study must include: |
722 | 1. The demographic characteristics of the individuals |
723 | assessed and diverted from nursing home placement, including, |
724 | but not limited to, age, race, gender, frailty, caregiver |
725 | status, living arrangements, and geographic location; |
726 | 2. A summary of community services provided to individuals |
727 | for 1 year after assessment and diversion; |
728 | 3. A summary of inpatient hospital admissions for |
729 | individuals who have been diverted; and |
730 | 4. A summary of the length of time between diversion and |
731 | subsequent entry into a nursing home or death. |
732 | (39)(a) The agency shall implement a Medicaid prescribed- |
733 | drug spending-control program that includes the following |
734 | components: |
735 | 1. A Medicaid preferred drug list, which shall be a |
736 | listing of cost-effective therapeutic options recommended by the |
737 | Medicaid Pharmacy and Therapeutics Committee established |
738 | pursuant to s. 409.91195 and adopted by the agency for each |
739 | therapeutic class on the preferred drug list. At the discretion |
740 | of the committee, and when feasible, the preferred drug list |
741 | should include at least two products in a therapeutic class. |
742 | Medicaid prescribed-drug coverage for brand-name drugs for adult |
743 | Medicaid recipients is limited to the dispensing of four brand- |
744 | name drugs per month per recipient. Children are exempt from |
745 | this restriction. Antiretroviral agents are excluded from the |
746 | preferred drug list this limitation. No requirements for prior |
747 | authorization or other restrictions on medications used to treat |
748 | mental illnesses such as schizophrenia, severe depression, or |
749 | bipolar disorder may be imposed on Medicaid recipients. |
750 | Medications that will be available without restriction for |
751 | persons with mental illnesses include atypical antipsychotic |
752 | medications, conventional antipsychotic medications, selective |
753 | serotonin reuptake inhibitors, and other medications used for |
754 | the treatment of serious mental illnesses. The agency shall also |
755 | limit the amount of a prescribed drug dispensed to no more than |
756 | a 34-day supply unless the drug products' smallest marketed |
757 | package is greater than a 34-day supply, or the drug is |
758 | determined by the agency to be a maintenance drug in which case |
759 | a 100-day maximum supply may be authorized. The agency is |
760 | authorized to seek any federal waivers necessary to implement |
761 | these cost-control programs and to continue participation in the |
762 | federal Medicaid rebate program, or alternatively to negotiate |
763 | state-only manufacturer rebates. The agency may adopt rules to |
764 | implement this subparagraph. The agency shall continue to |
765 | provide unlimited generic drugs, contraceptive drugs and items, |
766 | and diabetic supplies. Although a drug may be included on the |
767 | preferred drug formulary, it would not be exempt from the four- |
768 | brand limit. The agency may authorize exceptions to the brand- |
769 | name-drug restriction based upon the treatment needs of the |
770 | patients, only when such exceptions are based on prior |
771 | consultation provided by the agency or an agency contractor, but |
772 | The agency must establish procedures to ensure that: |
773 | a. There will be a response to a request for prior |
774 | consultation by telephone or other telecommunication device |
775 | within 24 hours after receipt of a request for prior |
776 | consultation; and |
777 | b. A 72-hour supply of the drug prescribed will be |
778 | provided in an emergency or when the agency does not provide a |
779 | response within 24 hours as required by sub-subparagraph a.; and |
780 | c. Except for the exception for nursing home residents and |
781 | other institutionalized adults and except for drugs on the |
782 | restricted formulary for which prior authorization may be sought |
783 | by an institutional or community pharmacy, prior authorization |
784 | for an exception to the brand-name-drug restriction is sought by |
785 | the prescriber and not by the pharmacy. When prior authorization |
786 | is granted for a patient in an institutional setting beyond the |
787 | brand-name-drug restriction, such approval is authorized for 12 |
788 | months and monthly prior authorization is not required for that |
789 | patient. |
790 | 2. Reimbursement to pharmacies for Medicaid prescribed |
791 | drugs shall be set at the lesser of: the average wholesale price |
792 | (AWP) minus 15.4 percent, the wholesaler acquisition cost (WAC) |
793 | plus 5.75 percent, the federal upper limit (FUL), the state |
794 | maximum allowable cost (SMAC), or the usual and customary (UAC) |
795 | charge billed by the provider. |
796 | 3. The agency shall develop and implement a process for |
797 | managing the drug therapies of Medicaid recipients who are using |
798 | significant numbers of prescribed drugs each month. The |
799 | management process may include, but is not limited to, |
800 | comprehensive, physician-directed medical-record reviews, claims |
801 | analyses, and case evaluations to determine the medical |
802 | necessity and appropriateness of a patient's treatment plan and |
803 | drug therapies. The agency may contract with a private |
804 | organization to provide drug-program-management services. The |
805 | Medicaid drug benefit management program shall include |
806 | initiatives to manage drug therapies for HIV/AIDS patients, |
807 | patients using 20 or more unique prescriptions in a 180-day |
808 | period, and the top 1,000 patients in annual spending. The |
809 | agency shall enroll any Medicaid recipient in the drug benefit |
810 | management program if he or she meets the specifications of this |
811 | provision and is not enrolled in a Medicaid health maintenance |
812 | organization. |
813 | 4. The agency may limit the size of its pharmacy network |
814 | based on need, competitive bidding, price negotiations, |
815 | credentialing, or similar criteria. The agency shall give |
816 | special consideration to rural areas in determining the size and |
817 | location of pharmacies included in the Medicaid pharmacy |
818 | network. A pharmacy credentialing process may include criteria |
819 | such as a pharmacy's full-service status, location, size, |
820 | patient educational programs, patient consultation, disease- |
821 | management services, and other characteristics. The agency may |
822 | impose a moratorium on Medicaid pharmacy enrollment when it is |
823 | determined that it has a sufficient number of Medicaid- |
824 | participating providers. |
825 | 5. The agency shall develop and implement a program that |
826 | requires Medicaid practitioners who prescribe drugs to use a |
827 | counterfeit-proof prescription pad for Medicaid prescriptions. |
828 | The agency shall require the use of standardized counterfeit- |
829 | proof prescription pads by Medicaid-participating prescribers or |
830 | prescribers who write prescriptions for Medicaid recipients. The |
831 | agency may implement the program in targeted geographic areas or |
832 | statewide. |
833 | 6. The agency may enter into arrangements that require |
834 | manufacturers of generic drugs prescribed to Medicaid recipients |
835 | to provide rebates of at least 15.1 percent of the average |
836 | manufacturer price for the manufacturer's generic products. |
837 | These arrangements shall require that if a generic-drug |
838 | manufacturer pays federal rebates for Medicaid-reimbursed drugs |
839 | at a level below 15.1 percent, the manufacturer must provide a |
840 | supplemental rebate to the state in an amount necessary to |
841 | achieve a 15.1-percent rebate level. |
842 | 7. The agency may establish a preferred drug list as |
843 | described in this subsection formulary in accordance with 42 |
844 | U.S.C. s. 1396r-8, and, pursuant to the establishment of such |
845 | preferred drug list formulary, it is authorized to negotiate |
846 | supplemental rebates from manufacturers that are in addition to |
847 | those required by Title XIX of the Social Security Act and at no |
848 | less than 14 percent of the average manufacturer price as |
849 | defined in 42 U.S.C. s. 1936 on the last day of a quarter unless |
850 | the federal or supplemental rebate, or both, equals or exceeds |
851 | 29 percent. There is no upper limit on the supplemental rebates |
852 | the agency may negotiate. The agency may determine that specific |
853 | products, brand-name or generic, are competitive at lower rebate |
854 | percentages. Agreement to pay the minimum supplemental rebate |
855 | percentage will guarantee a manufacturer that the Medicaid |
856 | Pharmaceutical and Therapeutics Committee will consider a |
857 | product for inclusion on the preferred drug list formulary. |
858 | However, a pharmaceutical manufacturer is not guaranteed |
859 | placement on the preferred drug list formulary by simply paying |
860 | the minimum supplemental rebate. Agency decisions will be made |
861 | on the clinical efficacy of a drug and recommendations of the |
862 | Medicaid Pharmaceutical and Therapeutics Committee, as well as |
863 | the price of competing products minus federal and state rebates. |
864 | The agency is authorized to contract with an outside agency or |
865 | contractor to conduct negotiations for supplemental rebates. For |
866 | the purposes of this section, the term "supplemental rebates" |
867 | means cash rebates. Effective July 1, 2004, value-added programs |
868 | as a substitution for supplemental rebates are prohibited. The |
869 | agency is authorized to seek any federal waivers to implement |
870 | this initiative. |
871 | 8. The agency shall establish an advisory committee for |
872 | the purposes of studying the feasibility of using a restricted |
873 | drug formulary for nursing home residents and other |
874 | institutionalized adults. The committee shall be comprised of |
875 | seven members appointed by the Secretary of Health Care |
876 | Administration. The committee members shall include two |
877 | physicians licensed under chapter 458 or chapter 459; three |
878 | pharmacists licensed under chapter 465 and appointed from a list |
879 | of recommendations provided by the Florida Long-Term Care |
880 | Pharmacy Alliance; and two pharmacists licensed under chapter |
881 | 465. |
882 | 8.9. The Agency for Health Care Administration shall |
883 | expand home delivery of pharmacy products. To assist Medicaid |
884 | patients in securing their prescriptions and reduce program |
885 | costs, the agency shall expand its current mail-order-pharmacy |
886 | diabetes-supply program to include all generic and brand-name |
887 | drugs used by Medicaid patients with diabetes. Medicaid |
888 | recipients in the current program may obtain nondiabetes drugs |
889 | on a voluntary basis. This initiative is limited to the |
890 | geographic area covered by the current contract. The agency may |
891 | seek and implement any federal waivers necessary to implement |
892 | this subparagraph. |
893 | 9.10. The agency shall limit to one dose per month any |
894 | drug prescribed to treat erectile dysfunction. |
895 | 10.a.11.a. The agency may shall implement a Medicaid |
896 | behavioral drug management system. The agency may contract with |
897 | a vendor that has experience in operating behavioral drug |
898 | management systems to implement this program. The agency is |
899 | authorized to seek federal waivers to implement this program. |
900 | b. The agency, in conjunction with the Department of |
901 | Children and Family Services, may implement the Medicaid |
902 | behavioral drug management system that is designed to improve |
903 | the quality of care and behavioral health prescribing practices |
904 | based on best practice guidelines, improve patient adherence to |
905 | medication plans, reduce clinical risk, and lower prescribed |
906 | drug costs and the rate of inappropriate spending on Medicaid |
907 | behavioral drugs. The program may shall include the following |
908 | elements: |
909 | (I) Provide for the development and adoption of best |
910 | practice guidelines for behavioral health-related drugs such as |
911 | antipsychotics, antidepressants, and medications for treating |
912 | bipolar disorders and other behavioral conditions; translate |
913 | them into practice; review behavioral health prescribers and |
914 | compare their prescribing patterns to a number of indicators |
915 | that are based on national standards; and determine deviations |
916 | from best practice guidelines. |
917 | (II) Implement processes for providing feedback to and |
918 | educating prescribers using best practice educational materials |
919 | and peer-to-peer consultation. |
920 | (III) Assess Medicaid beneficiaries who are outliers in |
921 | their use of behavioral health drugs with regard to the numbers |
922 | and types of drugs taken, drug dosages, combination drug |
923 | therapies, and other indicators of improper use of behavioral |
924 | health drugs. |
925 | (IV) Alert prescribers to patients who fail to refill |
926 | prescriptions in a timely fashion, are prescribed multiple same- |
927 | class behavioral health drugs, and may have other potential |
928 | medication problems. |
929 | (V) Track spending trends for behavioral health drugs and |
930 | deviation from best practice guidelines. |
931 | (VI) Use educational and technological approaches to |
932 | promote best practices, educate consumers, and train prescribers |
933 | in the use of practice guidelines. |
934 | (VII) Disseminate electronic and published materials. |
935 | (VIII) Hold statewide and regional conferences. |
936 | (IX) Implement a disease management program with a model |
937 | quality-based medication component for severely mentally ill |
938 | individuals and emotionally disturbed children who are high |
939 | users of care. |
940 | c. If the agency is unable to negotiate a contract with |
941 | one or more manufacturers to finance and guarantee savings |
942 | associated with a behavioral drug management program by |
943 | September 1, 2004, the four-brand drug limit and preferred drug |
944 | list prior-authorization requirements shall apply to mental |
945 | health-related drugs, notwithstanding any provision in |
946 | subparagraph 1. The agency is authorized to seek federal waivers |
947 | to implement this policy. |
948 | 11.12. The agency is authorized to contract for drug |
949 | rebate administration, including, but not limited to, |
950 | calculating rebate amounts, invoicing manufacturers, negotiating |
951 | disputes with manufacturers, and maintaining a database of |
952 | rebate collections. |
953 | 12.13. The agency may specify the preferred daily dosing |
954 | form or strength for the purpose of promoting best practices |
955 | with regard to the prescribing of certain drugs as specified in |
956 | the General Appropriations Act and ensuring cost-effective |
957 | prescribing practices. |
958 | 13.14. The agency may require prior authorization for the |
959 | off-label use of Medicaid-covered prescribed drugs as specified |
960 | in the General Appropriations Act. The agency may, but is not |
961 | required to, prior-authorize preauthorize the use of a product: |
962 | a. For an indication not approved in labeling; |
963 | b. To comply with certain clinical guidelines; or |
964 | c. If the product has the potential for overuse, misuse, |
965 | or abuse for an indication not in the approved labeling. |
966 |
|
967 | The agency Prior authorization may require the prescribing |
968 | professional to provide information about the rationale and |
969 | supporting medical evidence for the off-label use of a drug. The |
970 | agency may post prior-authorization criteria and protocol and |
971 | updates to the list of drugs that are subject to prior |
972 | authorization on an Internet website without amending its rule |
973 | or engaging in additional rulemaking. |
974 | 14. The agency, in conjunction with the Pharmaceutical and |
975 | Therapeutics Committee, may require age-related prior |
976 | authorizations for certain prescribed drugs. The agency may |
977 | preauthorize the use of a drug for a recipient who may not meet |
978 | the age requirement or may exceed the length of therapy for use |
979 | of this product as recommended by the manufacturer and approved |
980 | by the Food and Drug Administration. Prior authorization may |
981 | require the prescribing professional to provide information |
982 | about the rationale and supporting medical evidence for the use |
983 | of a drug. |
984 | 15. The agency shall implement a step-therapy-prior |
985 | authorization-approval process for medications excluded from the |
986 | preferred drug list. Medications listed on the preferred drug |
987 | list must be used within the previous 12 months prior to the |
988 | alternative medications that are not listed. The step-therapy- |
989 | prior authorization may require the prescriber to use the |
990 | medications of a similar drug class or for a similar medical |
991 | indication unless contraindicated in the Food and Drug |
992 | Administration labeling. The trial period between the specified |
993 | steps may vary according to the medical indication. The step- |
994 | therapy-approval process shall be developed in accordance with |
995 | the committee as stated in s. 409.91195(7) and (8). A drug |
996 | product may be approved without meeting the step-therapy-prior- |
997 | authorization criteria if the prescribing physician provides the |
998 | agency with additional written medical or clinical documentation |
999 | that the product is medically necessary because: |
1000 | a. There is not a drug on the preferred drug list to treat |
1001 | the disease or medical condition which is an acceptable clinical |
1002 | alternative; |
1003 | b. The alternatives have been ineffective in the treatment |
1004 | of the beneficiary's disease; or |
1005 | c. Based on historic evidence and known characteristics of |
1006 | the patient and the drug, the drug is likely to be ineffective, |
1007 | or the number of doses have been ineffective. |
1008 |
|
1009 | The agency shall work with the physician to determine the best |
1010 | alternative for the patient. The agency may adopt rules waiving |
1011 | the requirements for written clinical documentation for specific |
1012 | drugs in limited clinical situations. |
1013 | 16.15. The agency shall implement a return and reuse |
1014 | program for drugs dispensed by pharmacies to institutional |
1015 | recipients, which includes payment of a $5 restocking fee for |
1016 | the implementation and operation of the program. The return and |
1017 | reuse program shall be implemented electronically and in a |
1018 | manner that promotes efficiency. The program must permit a |
1019 | pharmacy to exclude drugs from the program if it is not |
1020 | practical or cost-effective for the drug to be included and must |
1021 | provide for the return to inventory of drugs that cannot be |
1022 | credited or returned in a cost-effective manner. |
1023 | (44) The Agency for Health Care Administration shall |
1024 | ensure that any Medicaid managed care plan as defined in s. |
1025 | 409.9122(2)(h), whether paid on a capitated basis or a shared |
1026 | savings basis, is cost-effective. For purposes of this |
1027 | subsection, the term "cost-effective" means that a network's |
1028 | per-member, per-month costs to the state, including, but not |
1029 | limited to, fee-for-service costs, administrative costs, and |
1030 | case-management fees, if any, must be no greater than the |
1031 | state's costs associated with contracts for Medicaid services |
1032 | established under subsection (3), which shall be actuarially |
1033 | adjusted for case mix, model, and service area. The agency shall |
1034 | conduct actuarially sound audits adjusted for case mix and model |
1035 | in order to ensure such cost-effectiveness and shall publish the |
1036 | audit results on its Internet website and submit the audit |
1037 | results annually to the Governor, the President of the Senate, |
1038 | and the Speaker of the House of Representatives no later than |
1039 | December 31 of each year. Contracts established pursuant to this |
1040 | subsection which are not cost-effective may not be renewed. |
1041 | (49) The agency shall contract with established minority |
1042 | physician networks that provide services to historically |
1043 | underserved minority patients. The networks must provide cost- |
1044 | effective Medicaid services, comply with the requirements to be |
1045 | a MediPass provider, and provide their primary care physicians |
1046 | with access to data and other management tools necessary to |
1047 | assist them in ensuring the appropriate use of services, |
1048 | including inpatient hospital services and pharmaceuticals. |
1049 | (a) The agency shall provide for the development and |
1050 | expansion of minority physician networks in each service area to |
1051 | provide services to Medicaid recipients who are eligible to |
1052 | participate under federal law and rules. |
1053 | (b) The agency shall reimburse each minority physician |
1054 | network as a fee-for-service provider, including the case |
1055 | management fee for primary care, if any, or as a capitated rate |
1056 | provider for Medicaid services. Any savings shall be shared with |
1057 | the minority physician networks pursuant to the contract. |
1058 | (c) For purposes of this subsection, the term "cost- |
1059 | effective" means that a network's per-member, per-month costs to |
1060 | the state, including, but not limited to, fee-for-service costs, |
1061 | administrative costs, and case-management fees, if any, must be |
1062 | no greater than the state's costs associated with contracts for |
1063 | Medicaid services established under subsection (3), which shall |
1064 | be actuarially adjusted for case mix, model, and service area. |
1065 | The agency shall conduct actuarially sound audits adjusted for |
1066 | case mix and model in order to ensure such cost-effectiveness |
1067 | and shall publish the audit results on its Internet website and |
1068 | submit the audit results annually to the Governor, the President |
1069 | of the Senate, and the Speaker of the House of Representatives |
1070 | no later than December 31. Contracts established pursuant to |
1071 | this subsection which are not cost-effective may not be renewed. |
1072 | (d) The agency may apply for any federal waivers needed to |
1073 | implement this subsection. |
1074 | (50) The agency shall implement a program of all-inclusive |
1075 | care for children. The program of all-inclusive care for |
1076 | children shall be established to provide in-home hospice-like |
1077 | support services to children diagnosed with a life-threatening |
1078 | illness and enrolled in the Children's Medical Services network |
1079 | to reduce hospitalizations as appropriate. The agency, in |
1080 | consultation with the Department of Health, may implement the |
1081 | program of all-inclusive care for children after obtaining |
1082 | approval from the Centers for Medicare and Medicaid Services. |
1083 | Section 14. Paragraph (k) of subsection (2) of section |
1084 | 409.9122, Florida Statutes, is amended to read: |
1085 | 409.9122 Mandatory Medicaid managed care enrollment; |
1086 | programs and procedures.-- |
1087 | (2) |
1088 | (k) When a Medicaid recipient does not choose a managed |
1089 | care plan or MediPass provider, the agency shall assign the |
1090 | Medicaid recipient to a managed care plan, except in those |
1091 | counties in which there are fewer than two managed care plans |
1092 | accepting Medicaid enrollees, in which case assignment shall be |
1093 | to a managed care plan or a MediPass provider. Medicaid |
1094 | recipients in counties with fewer than two managed care plans |
1095 | accepting Medicaid enrollees who are subject to mandatory |
1096 | assignment but who fail to make a choice shall be assigned to |
1097 | managed care plans until an enrollment of 40 percent in MediPass |
1098 | and 60 percent in managed care plans is achieved. Once that |
1099 | enrollment is achieved, the assignments shall be divided in |
1100 | order to maintain an enrollment in MediPass and managed care |
1101 | plans which is in a 40 percent and 60 percent proportion, |
1102 | respectively. In service areas 1 and 6 of the Agency for Health |
1103 | Care Administration geographic areas where the agency is |
1104 | contracting for the provision of comprehensive behavioral health |
1105 | services through a capitated prepaid arrangement, recipients who |
1106 | fail to make a choice shall be assigned equally to MediPass or a |
1107 | managed care plan. For purposes of this paragraph, when |
1108 | referring to assignment, the term "managed care plans" includes |
1109 | exclusive provider organizations, provider service networks, |
1110 | Children's Medical Services Network, minority physician |
1111 | networks, and pediatric emergency department diversion programs |
1112 | authorized by this chapter or the General Appropriations Act. |
1113 | When making assignments, the agency shall take into account the |
1114 | following criteria: |
1115 | 1. A managed care plan has sufficient network capacity to |
1116 | meet the need of members. |
1117 | 2. The managed care plan or MediPass has previously |
1118 | enrolled the recipient as a member, or one of the managed care |
1119 | plan's primary care providers or MediPass providers has |
1120 | previously provided health care to the recipient. |
1121 | 3. The agency has knowledge that the member has previously |
1122 | expressed a preference for a particular managed care plan or |
1123 | MediPass provider as indicated by Medicaid fee-for-service |
1124 | claims data, but has failed to make a choice. |
1125 | 4. The managed care plan's or MediPass primary care |
1126 | providers are geographically accessible to the recipient's |
1127 | residence. |
1128 | 5. The agency has authority to make mandatory assignments |
1129 | based on quality of service and performance of managed care |
1130 | plans. |
1131 | Section 15. Section 409.9124, Florida Statutes, is amended |
1132 | to read: |
1133 | 409.9124 Managed care reimbursement.-- |
1134 | (1) The agency shall develop and adopt by rule a |
1135 | methodology for reimbursing managed care plans. |
1136 | (1)(2) Final managed care rates shall be published |
1137 | annually prior to September 1 of each year, based on methodology |
1138 | that: |
1139 | (a) Uses Medicaid's fee-for-service expenditures. |
1140 | (b) Is certified as an actuarially sound computation of |
1141 | Medicaid fee-for-service expenditures for comparable groups of |
1142 | Medicaid recipients and includes all fee-for-service |
1143 | expenditures, including those fee-for-service expenditures |
1144 | attributable to recipients who are enrolled for a portion of a |
1145 | year in a managed care plan or waiver program. |
1146 | (c) Is compliant with applicable federal laws and |
1147 | regulations, including, but not limited to, the requirements to |
1148 | include an allowance for administrative expenses and to account |
1149 | for all fee-for-service expenditures, including fee-for-service |
1150 | expenditures for those groups enrolled for part of a year. |
1151 | (2)(3) Each year prior to establishing new managed care |
1152 | rates, the agency shall review all prior year adjustments for |
1153 | changes in trend, and shall reduce or eliminate those |
1154 | adjustments which are not reasonable and which reflect policies |
1155 | or programs which are not in effect. In addition, the agency |
1156 | shall apply only those policy reductions applicable to the |
1157 | fiscal year for which the rates are being set, which can be |
1158 | accurately estimated and verified by an independent actuary, and |
1159 | which have been implemented prior to or will be implemented |
1160 | during the fiscal year. The agency shall pay rates at per- |
1161 | member, per-month averages that equal, but do not exceed, the |
1162 | amounts allowed for in the General Appropriations Act applicable |
1163 | to the fiscal year for which the rates will be in effect. |
1164 | (3)(4) The agency shall by rule prescribe those items of |
1165 | financial information which each managed care plan shall report |
1166 | to the agency, in the time periods prescribed by rule. In |
1167 | prescribing items for reporting and definitions of terms, the |
1168 | agency shall consult with the Office of Insurance Regulation of |
1169 | the Financial Services Commission wherever possible. |
1170 | (4)(5) The agency shall quarterly examine the financial |
1171 | condition of each managed care plan, and its performance in |
1172 | serving Medicaid patients, and shall utilize examinations |
1173 | performed by the Office of Insurance Regulation wherever |
1174 | possible. |
1175 | (5) The agency shall develop two rates for children under |
1176 | 1 year of age. One set of rates shall cover the month of birth |
1177 | through the second complete month subsequent to the month of |
1178 | birth, and a separate set of rates shall cover the third |
1179 | complete month subsequent to the month of birth through the |
1180 | eleventh complete month subsequent to the month of birth. The |
1181 | agency shall amend the payment methodology for participating |
1182 | Medicaid-managed health care plans to comply with this |
1183 | subsection. |
1184 | Section 16. Section 430.041, Florida Statutes, is |
1185 | repealed. |
1186 | Section 17. Subsection (1) of section 430.502, Florida |
1187 | Statutes, is amended to read: |
1188 | 430.502 Alzheimer's disease; memory disorder clinics and |
1189 | day care and respite care programs.-- |
1190 | (1) There is established: |
1191 | (a) A memory disorder clinic at each of the three medical |
1192 | schools in this state; |
1193 | (b) A memory disorder clinic at a major private nonprofit |
1194 | research-oriented teaching hospital, and may fund a memory |
1195 | disorder clinic at any of the other affiliated teaching |
1196 | hospitals; |
1197 | (c) A memory disorder clinic at the Mayo Clinic in |
1198 | Jacksonville; |
1199 | (d) A memory disorder clinic at the West Florida Regional |
1200 | Medical Center; |
1201 | (e) The East Central Florida Memory Disorder Clinic at the |
1202 | Joint Center for Advanced Therapeutics and Biomedical Research |
1203 | of the Florida Institute of Technology and Holmes Regional |
1204 | Medical Center, Inc.; |
1205 | (f) A memory disorder clinic at the Orlando Regional |
1206 | Healthcare System, Inc.; |
1207 | (g) A memory disorder center located in a public hospital |
1208 | that is operated by an independent special hospital taxing |
1209 | district that governs multiple hospitals and is located in a |
1210 | county with a population greater than 800,000 persons; |
1211 | (h) A memory disorder clinic at St. Mary's Medical Center |
1212 | in Palm Beach County; |
1213 | (i) A memory disorder clinic at Tallahassee Memorial |
1214 | Healthcare; |
1215 | (j) A memory disorder clinic at Lee Memorial Hospital |
1216 | created by chapter 63-1552, Laws of Florida, as amended; |
1217 | (k) A memory disorder clinic at Sarasota Memorial Hospital |
1218 | in Sarasota County; and |
1219 | (l) A memory disorder clinic at Morton Plant Hospital, |
1220 | Clearwater, in Pinellas County; and, |
1221 | (m) A memory disorder clinic at Florida Atlantic |
1222 | University, Boca Raton, in Palm Beach County, |
1223 |
|
1224 | for the purpose of conducting research and training in a |
1225 | diagnostic and therapeutic setting for persons suffering from |
1226 | Alzheimer's disease and related memory disorders. However, |
1227 | memory disorder clinics funded as of June 30, 1995, shall not |
1228 | receive decreased funding due solely to subsequent additions of |
1229 | memory disorder clinics in this subsection. |
1230 | Section 18. Paragraph (d) of subsection (15) of section |
1231 | 440.02, Florida Statutes, is amended to read: |
1232 | 440.02 Definitions.--When used in this chapter, unless the |
1233 | context clearly requires otherwise, the following terms shall |
1234 | have the following meanings: |
1235 | (15) |
1236 | (d) "Employee" does not include: |
1237 | 1. An independent contractor who is not engaged in the |
1238 | construction industry. |
1239 | a. In order to meet the definition of independent |
1240 | contractor, at least four of the following criteria must be met: |
1241 | (I) The independent contractor maintains a separate |
1242 | business with his or her own work facility, truck, equipment, |
1243 | materials, or similar accommodations; |
1244 | (II) The independent contractor holds or has applied for a |
1245 | federal employer identification number, unless the independent |
1246 | contractor is a sole proprietor who is not required to obtain a |
1247 | federal employer identification number under state or federal |
1248 | regulations; |
1249 | (III) The independent contractor receives compensation for |
1250 | services rendered or work performed and such compensation is |
1251 | paid to a business rather than to an individual; |
1252 | (IV) The independent contractor holds one or more bank |
1253 | accounts in the name of the business entity for purposes of |
1254 | paying business expenses or other expenses related to services |
1255 | rendered or work performed for compensation; |
1256 | (V) The independent contractor performs work or is able to |
1257 | perform work for any entity in addition to or besides the |
1258 | employer at his or her own election without the necessity of |
1259 | completing an employment application or process; or |
1260 | (VI) The independent contractor receives compensation for |
1261 | work or services rendered on a competitive-bid basis or |
1262 | completion of a task or a set of tasks as defined by a |
1263 | contractual agreement, unless such contractual agreement |
1264 | expressly states that an employment relationship exists. |
1265 | b. If four of the criteria listed in sub-subparagraph a. |
1266 | do not exist, an individual may still be presumed to be an |
1267 | independent contractor and not an employee based on full |
1268 | consideration of the nature of the individual situation with |
1269 | regard to satisfying any of the following conditions: |
1270 | (I) The independent contractor performs or agrees to |
1271 | perform specific services or work for a specific amount of money |
1272 | and controls the means of performing the services or work. |
1273 | (II) The independent contractor incurs the principal |
1274 | expenses related to the service or work that he or she performs |
1275 | or agrees to perform. |
1276 | (III) The independent contractor is responsible for the |
1277 | satisfactory completion of the work or services that he or she |
1278 | performs or agrees to perform. |
1279 | (IV) The independent contractor receives compensation for |
1280 | work or services performed for a commission or on a per-job |
1281 | basis and not on any other basis. |
1282 | (V) The independent contractor may realize a profit or |
1283 | suffer a loss in connection with performing work or services. |
1284 | (VI) The independent contractor has continuing or |
1285 | recurring business liabilities or obligations. |
1286 | (VII) The success or failure of the independent |
1287 | contractor's business depends on the relationship of business |
1288 | receipts to expenditures. |
1289 | c. Notwithstanding anything to the contrary in this |
1290 | subparagraph, an individual claiming to be an independent |
1291 | contractor has the burden of proving that he or she is an |
1292 | independent contractor for purposes of this chapter. |
1293 | 2. A real estate licensee, if that person agrees, in |
1294 | writing, to perform for remuneration solely by way of |
1295 | commission. |
1296 | 3. Bands, orchestras, and musical and theatrical |
1297 | performers, including disk jockeys, performing in licensed |
1298 | premises as defined in chapter 562, if a written contract |
1299 | evidencing an independent contractor relationship is entered |
1300 | into before the commencement of such entertainment. |
1301 | 4. An owner-operator of a motor vehicle who transports |
1302 | property under a written contract with a motor carrier which |
1303 | evidences a relationship by which the owner-operator assumes the |
1304 | responsibility of an employer for the performance of the |
1305 | contract, if the owner-operator is required to furnish the |
1306 | necessary motor vehicle equipment and all costs incidental to |
1307 | the performance of the contract, including, but not limited to, |
1308 | fuel, taxes, licenses, repairs, and hired help; and the owner- |
1309 | operator is paid a commission for transportation service and is |
1310 | not paid by the hour or on some other time-measured basis. |
1311 | 5. A person whose employment is both casual and not in the |
1312 | course of the trade, business, profession, or occupation of the |
1313 | employer. |
1314 | 6. A volunteer, except a volunteer worker for the state or |
1315 | a county, municipality, or other governmental entity. A person |
1316 | who does not receive monetary remuneration for services is |
1317 | presumed to be a volunteer unless there is substantial evidence |
1318 | that a valuable consideration was intended by both employer and |
1319 | employee. For purposes of this chapter, the term "volunteer" |
1320 | includes, but is not limited to: |
1321 | a. Persons who serve in private nonprofit agencies and who |
1322 | receive no compensation other than expenses in an amount less |
1323 | than or equivalent to the standard mileage and per diem expenses |
1324 | provided to salaried employees in the same agency or, if such |
1325 | agency does not have salaried employees who receive mileage and |
1326 | per diem, then such volunteers who receive no compensation other |
1327 | than expenses in an amount less than or equivalent to the |
1328 | customary mileage and per diem paid to salaried workers in the |
1329 | community as determined by the department; and |
1330 | b. Volunteers participating in federal programs |
1331 | established under Pub. L. No. 93-113. |
1332 | 7. Unless otherwise prohibited by this chapter, any |
1333 | officer of a corporation who elects to be exempt from this |
1334 | chapter. Such officer is not an employee for any reason under |
1335 | this chapter until the notice of revocation of election filed |
1336 | pursuant to s. 440.05 is effective. |
1337 | 8. An officer of a corporation that is engaged in the |
1338 | construction industry who elects to be exempt from the |
1339 | provisions of this chapter, as otherwise permitted by this |
1340 | chapter. Such officer is not an employee for any reason until |
1341 | the notice of revocation of election filed pursuant to s. 440.05 |
1342 | is effective. |
1343 | 9. An exercise rider who does not work for a single horse |
1344 | farm or breeder, and who is compensated for riding on a case-by- |
1345 | case basis, provided a written contract is entered into prior to |
1346 | the commencement of such activity which evidences that an |
1347 | employee/employer relationship does not exist. |
1348 | 10. A taxicab, limousine, or other passenger vehicle-for- |
1349 | hire driver who operates said vehicles pursuant to a written |
1350 | agreement with a company which provides any dispatch, marketing, |
1351 | insurance, communications, or other services under which the |
1352 | driver and any fees or charges paid by the driver to the company |
1353 | for such services are not conditioned upon, or expressed as a |
1354 | proportion of, fare revenues. |
1355 | 11. A person who performs services as a sports official |
1356 | for an entity sponsoring an interscholastic sports event or for |
1357 | a public entity or private, nonprofit organization that sponsors |
1358 | an amateur sports event. For purposes of this subparagraph, such |
1359 | a person is an independent contractor. For purposes of this |
1360 | subparagraph, the term "sports official" means any person who is |
1361 | a neutral participant in a sports event, including, but not |
1362 | limited to, umpires, referees, judges, linespersons, |
1363 | scorekeepers, or timekeepers. This subparagraph does not apply |
1364 | to any person employed by a district school board who serves as |
1365 | a sports official as required by the employing school board or |
1366 | who serves as a sports official as part of his or her |
1367 | responsibilities during normal school hours. |
1368 | 12. Medicaid-enrolled clients under chapter 393 who are |
1369 | excluded from the definition of employment under s. |
1370 | 443.1216(4)(d) and served by Adult Day Training Services under |
1371 | the Home and Community-Based or the Family and Supported Living |
1372 | Medicaid Waiver program in a sheltered workshop setting licensed |
1373 | by the United States Department of Labor for the purpose of |
1374 | training and earning less than the federal hourly minimum wage. |
1375 | Section 19. Section 21 of chapter 2004-270, Laws of |
1376 | Florida, is amended to read: |
1377 | Section 20. Notwithstanding s. 430.707, Florida Statutes, |
1378 | no later than September 1, 2005, or subject to federal approval |
1379 | of the application to be a Program of All-inclusive Care for the |
1380 | Elderly site, the agency shall contract with one private, not- |
1381 | for-profit hospice organization located in Lee County and one |
1382 | such organization in Martin County, such an entity shall be |
1383 | exempt from the requirements of chapter 641 Florida Statutes, |
1384 | each of which provides comprehensive services, including hospice |
1385 | care for frail and elderly persons. The agency shall approve 100 |
1386 | initial enrollees in the Program of All-inclusive Care for the |
1387 | Elderly for the in Lee and Martin programs, subject to an |
1388 | appropriation by the Legislature counties. The organization in |
1389 | Lee County shall serve eligible residents in Lee County and in |
1390 | the counties contiguous to Lee County. The organization in |
1391 | Martin County shall serve eligible residents in Martin County |
1392 | and in the counties contiguous to Martin County. Each program |
1393 | may continue to enroll eligible residents when the Agency for |
1394 | Health Care Administration determines such residents to be |
1395 | eligible for nursing home confinement. Residents currently |
1396 | designated by the agency as eligible for nursing home |
1397 | confinement are automatically eligible for PACE program |
1398 | enrollment. There shall be 50 initial enrollees in each county. |
1399 |
|
1400 | ================= T I T L E A M E N D M E N T ================= |
1401 | On page 77, line(s) 14, through page 79, line 20 |
1402 | remove: all of said lines |
1403 |
|
1404 | and insert: |
1405 | expense assistance; amending ss. 409.911, 409.9112, 409.9113, |
1406 | 409.9117, F.S., relating to the hospital disproportionate share |
1407 | program; revising the method for calculating the |
1408 | disproportionate share payment; deleting obsolete provisions; |
1409 | amending s. 409.91195, F.S.; revising provisions relating to the |
1410 | Medicaid Pharmaceutical and Therapeutics Committee and its |
1411 | duties with respect to developing a preferred drug list; |
1412 | amending s. 409.912, F.S.; authorizing the agency to contract |
1413 | with comprehensive behavioral health care providers in a |
1414 | specified service area for the purpose of demonstrating the |
1415 | cost-effectiveness of quality mental health services through a |
1416 | public hospital-operated managed care model; providing |
1417 | requirements for the contract; revising the Medicaid prescribed |
1418 | drug spending control program; eliminating case management fees; |
1419 | directing the Agency for Health Care Administration to |
1420 | implement, and authorizing it to seek federal waivers for, the |
1421 | program of all-inclusive care for children; authorizing the |
1422 | agency to adopt rules; amending s. 409.9122, F.S.; revising a |
1423 | provision governing assignment to a managed care option for a |
1424 | Medicaid recipient who does not choose a plan or provider in |
1425 | certain geographic areas where the Agency for Health Care |
1426 | Administration contracts for comprehensive behavioral health |
1427 | services; amending s. 409.9124, F.S.; requiring the Agency for |
1428 | Health Care Administration to publish managed care reimbursement |
1429 | rates annually; limiting the application of certain rates and |
1430 | rate reductions; providing for rates applicable to children |
1431 | under 1 year of age; repealing s. 430.041, F.S., relating to |
1432 | establishing the Office of Long-Term Care Policy; amending s. |
1433 | 430.502, F.S.; establishing a memory disorder clinic at Florida |
1434 | Atlantic University; amending s. 440.02, F.S.; excluding from |
1435 | the term "employee" as used in ch. 440, F.S., certain Medicaid- |
1436 | enrolled clients served under the Family and Supported Living |
1437 | Medicaid Waiver program; amending s. 21, ch. 2004-270, Laws of |
1438 | Florida; providing criteria for clientele to be served by |
1439 | organizations in Lee County and Martin County under the Program |
1440 | of All-inclusive Care for the Elderly; providing for |
1441 | severability; |